NEPHROPLUS Share Price | Nephrocare Health Services Ltd Stock Analysis & Recommendation

Upcoming Result: Nephrocare Healt will declare its result soon on 19 May 2026

Technical Trend Update: Nephrocare Healt witnessed a change in Technical Grade on 06 May 2026. Click here to discover latest technical change!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

79.2 k (-18.03%) Volume

Shareholding (Mar 2026)

FII

9.94%

Held by 20 FIIs

DII

3.97%

Held by 8 DIIs

Promoter

63.85%

Why is Nephrocare Health Services Ltd falling/rising?

06-May-2026

As of 05-May, Nephrocare Health Services Ltd's stock price is Rs 536.80, down 1.94%, and has underperformed its sector. The stock shows signs of short-term weakness with declining investor participation and is trading below its 20-day and 50-day moving averages.

View full answer

Which are the latest news on Nephrocare Healt?

06-May-2026

No latest news for Nephrocare Healt found.

Compare Nephrocare Healt with Similar Stocks

Suven Life Scie.Vimta Labs Thyrocare Tech.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Healthcare Services

Market cap

INR 5,359 Cr (Small Cap)

P/E

80.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.02

Return on Equity

11.74%

Price to Book

9.48

Revenue and Profits:

Net Sales:

260 Cr

(Quarterly Results - Dec 2025)

Net Profit:

32 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.8%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Nephrocare Healt for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Board Meeting Intimation for Intimation Of Board Meeting For Considering Audited Financial Results Of The Company.

04-May-2026 | Source : BSE

Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2026.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

04-May-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI Listing Regulations we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday 20th May 2026 at 16:00 IST to discuss the Audited Financial Results of the Company for the quarter and financial year ended 31st March 2026. A copy of the invitation is also attached for your information

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

10-Apr-2026 | Source : BSE

We are enclosing herewith a certificate under Reg 74(5) of SEBI (DP) Regulations 2018 for quarter ended 31st March 2026 received from M/s. KFIN Technologies Limited.

Corporate Actions

BOARD MEETING

19 May 2026

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

4.52

Debt to EBITDA (avg)

4.40

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.83

Tax Ratio

23.26%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

18.58%

ROCE (avg)

4.47%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

9.38

EV to EBIT

56.86

EV to EBITDA

32.13

EV to Capital Employed

9.52

EV to Sales

7.08

PEG Ratio

Dividend Yield

ROCE (Latest)

16.74%

ROE (Latest)

11.74%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Sideways

KST

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 7 Schemes (3.17%)

FIIs

Held by 20 FIIs (9.94%)

Promoter with highest holding

Edoras Investment Holdings Pte Ltd (28.3%)

Highest Public shareholder

Investcorp India Investments Holding Limited (6.29%)

Individual Investors Holdings

5.08%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 3.04% vs 12.81% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 126.07% vs -499.14% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "160.66",
          "val2": "155.92",
          "chgp": "3.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.86",
          "val2": "23.47",
          "chgp": "-2.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.96",
          "val2": "41.05",
          "chgp": "-90.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.45",
          "val2": "-32.41",
          "chgp": "126.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.23%",
          "val2": "15.05%",
          "chgp": "-0.82%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Nephrocare Healt"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Nephrocare Healt"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "543.60",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "94.89",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "14.30",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "34.24",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.46%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

160.66

155.92

3.04%

Operating Profit (PBDIT) excl Other Income

22.86

23.47

-2.60%

Interest

3.96

41.05

-90.35%

Exceptional Items

0.00

Standalone Net Profit

8.45

-32.41

126.07%

Operating Profit Margin (Excl OI)

14.23%

15.05%

-0.82%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.04% vs 12.81% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 126.07% vs -499.14% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

543.60

Operating Profit (PBDIT) excl Other Income

94.89

Interest

14.30

Exceptional Items

0.00

Standalone Net Profit

34.24

Operating Profit Margin (Excl OI)

17.46%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Nephrocare Health Services Ltd

Nephrocare Health Services Ltd

Small Cap

Healthcare Services

No Details Available.

Company Coordinates

No Company Details Available